IPI Resident Scholar Merrill Matthews joins KMED's Bill Meyer Show to discuss the basis of employee mandates on the Covid vaccine and other health and safety measures.
IPI Resident Scholar Dr. Merrill Matthews leads a discussion about whether private employers can require vaccination for their employees, what exceptions might be possible, whether private businesses can require vaccinations or masks of their customers, and other related issues. It’s a great chance to think through the differences between government and the private sector, and to think about how different levels of government relate to each other, says IPI President Tom Giovanetti.
Tom Giovanetti and Mark Davis (660AM the Answer) discuss the new reality of co-existing with Covid-19 and how this impacts the continuing struggle between state and local control.
In a conversation between IPI President Tom Giovanetti and Resident Scholar Dr. Merrill Matthews, we discuss how the vaccine issue has been politicized by both sides, not just one. And that vaccine hesitancy is bipartisan.
IPI Resident Scholar Dr. Merrill Matthews, an expert on health care policy, discusses the relative responses of Presidents Donald Trump, Joe Biden, and the CDC to the Covid-19 pandemic, with contributions by IPI President Tom Giovanetti.
IPI Policy Basics: Prescription Drug Development and the Miracle of the Covid-19 Vaccine(s) (Audio: Podcast)
IPI Resident Scholar Dr. Merrill Matthews describes some of the hurdles of prescription drug development, why the development of the Covid-19 vaccines is such a success story, and what we might learn from this experience. With comments by IPI president Tom Giovanetti.
IPI Resident Scholar Dr. Merrill Matthews explains that, if the reality of Obamacare was everything we were told it would be, there would be no need for President Biden to advocate expanding Medicare eligibility. And how Biden’s plan will hasten the bankruptcy of Medicare and the impending entitlements crisis. With occasional cackling and contributions by IPI President Tom Giovanetti.
Fundamentally, until consumers are in charge of their own health care spending, healthcare cannot be disrupted, and thus companies like Amazon can only tinker around the edges.
IPI President Tom Giovanetti is joined by Research Fellow Bartlett Cleland to discuss the government’s approach to Covid-19, how we manage relative risk, and policy implications such as the precautionary principle.
Importing drugs from other countries was first embraced by Democrats and now by some Republicans as a way of lowering Americans’ drug spending. But if there’s such a great demand, why has it never worked when implemented at scale? And why won’t anyone take FL Governor Ron DeSantis’ $30 million offer for a company to implement it in Florida? Hint: It might have to do with Medicare Part D, generic drugs, and the danger of counterfeiting.